Loading organizations...
§ Private Profile · Daxing, Beijing, China
Xiji Bio focuses on the cell and gene therapy (CGT) field, providing CDMO services covering plasmids, viral vectors, and cell products
Xiji Biotechnology provides CDMO services for plasmids, viral vectors, and cell products, and also offers analytical services such as metabolomics detection for research.
Yes, Xiji Biotechnology has partnered with MGI Tech to jointly promote the standardized application and market development of technologies relevant to their field.
Xiji Biotechnology provides CDMO services for plasmids, viral vectors, and cell products, and also offers analytical services such as metabolomics detection for research.
Yes, Xiji Biotechnology has partnered with MGI Tech to jointly promote the standardized application and market development of technologies relevant to their field.
Xiji Biotechnology most recently raised Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 9, 2026 | Series A | — | Shennong Capital, Shunxi Fund, Zhixuan Wealth | Announced |